Jenna M. Whalen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jenna M. Whalen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Arthur M. Mercurio
Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA
7 shared publications - Christi Wisniewski
University of Massachusetts Chan Medical School Department of Molecular, Cell, and Cancer Biology Worcester, Massachusetts
7 shared publications - Nathan MacGilvary
Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, United States of America
7 shared publications - Sharon B. Cantor
Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA
7 shared publications - Tokio Sano
University of Massachusetts Chan Medical School Department of Molecular, Cell, and Cancer Biology Worcester, Massachusetts
7 shared publications - Catherine H. Freudenreich
Department of Biology, Tufts University , Medford, MA 02155
1 shared publication
Latest Publications
- Open Access
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
BRCA-deficient cells have an inherent gap phenotype
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
BRCA-deficient cells have an inherent gap phenotype
- Open Access
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Data from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
Single-stranded DNA (ssDNA) gaps represent an underappreciated vulnerability that directly shapes therapeutic response in BRCA-deficient models. Current clinical biomarkers remain anchored to the double-strand break–centric model of homologous recombination deficiency, and there are currently no tools available to detect replication-associated gaps in the clinical setting. In this study, we developed a scalable, clinically adaptable assay that enables real-time, drug-free detection of gaps. This assay demonstrated that gaps are intrinsically elevated in BRCA-deficient cells independent of exogenous DNA damage. These gaps arose during DNA replication and were generated through PRIMPOL-dependent repriming at abasic sites and nuclease-mediated processing. Across diverse cell line models, PARP inhibitor (PARPi) sensitivity was associated with gap burden irrespective of BRCA status, extending the relevance of this vulnerability beyond canonical BRCA-mutant contexts. Integration with artificial intelligence–driven image analysis enabled automated, unbiased quantification of gap levels in xenograft tumor specimens. In BRCA-deficient xenografts, elevated gap levels were associated with PARPi sensitivity, supporting their translational relevance in relation to therapeutic response. Together, these findings establish ssDNA gaps as a real-time functional readout associated with chemotherapy response and introduce an assay with potential for future clinical translation. Significance:Single-stranded DNA gaps are an intrinsic feature of therapy-sensitive cancer cells, representing a functional biomarker that captures replication-associated vulnerabilities.
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
Single-stranded DNA (ssDNA) gaps represent an underappreciated vulnerability that directly shapes therapeutic response in BRCA-deficient models. Current clinical biomarkers remain anchored to the double-strand break–centric model of homologous recombination deficiency, and there are currently no tools available to detect replication-associated gaps in the clinical setting. In this study, we developed a scalable, clinically adaptable assay that enables real-time, drug-free detection of gaps. This assay demonstrated that gaps are intrinsically elevated in BRCA-deficient cells independent of exogenous DNA damage. These gaps arose during DNA replication and were generated through PRIMPOL-dependent repriming at abasic sites and nuclease-mediated processing. Across diverse cell line models, PARP inhibitor (PARPi) sensitivity was associated with gap burden irrespective of BRCA status, extending the relevance of this vulnerability beyond canonical BRCA-mutant contexts. Integration with artificial intelligence–driven image analysis enabled automated, unbiased quantification of gap levels in xenograft tumor specimens. In BRCA-deficient xenografts, elevated gap levels were associated with PARPi sensitivity, supporting their translational relevance in relation to therapeutic response. Together, these findings establish ssDNA gaps as a real-time functional readout associated with chemotherapy response and introduce an assay with potential for future clinical translation. Significance:Single-stranded DNA gaps are an intrinsic feature of therapy-sensitive cancer cells, representing a functional biomarker that captures replication-associated vulnerabilities.
- Open Access
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
The gap detection assay detects gaps induced by genotoxic agents and trapping by PARPi.
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
The gap detection assay detects gaps induced by genotoxic agents and trapping by PARPi.
- Open Access
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
The gap detection assay detects gaps linked to replication, abasic sites, PRIMPOL, and resection in BRCA1-deficient cells.
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
The gap detection assay detects gaps linked to replication, abasic sites, PRIMPOL, and resection in BRCA1-deficient cells.
- Open Access
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
AI-based gap detection assay quantification is associated with PARPi sensitivity in BRCA1-deficient tumors.
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
AI-based gap detection assay quantification is associated with PARPi sensitivity in BRCA1-deficient tumors.
- Open Access
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
The gap detection assay detects gaps linked to replication, abasic sites, PRIMPOL, and resection in BRCA1-deficient cells.
- 16 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
The gap detection assay detects gaps linked to replication, abasic sites, PRIMPOL, and resection in BRCA1-deficient cells.
- Open Access
- 8 September 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 86 (22) , 5822-5836
Detection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
Single-stranded DNA (ssDNA) gaps represent an underappreciated vulnerability that directly shapes therapeutic response in BRCA-deficient models. Current clinical biomarkers remain anchored to the double-strand break–centric model of homologous recombination deficiency, and there are currently no tools available to detect replication-associated gaps in the clinical setting. In this study, we developed a scalable, clinically adaptable assay that enables real-time, drug-free detection of gaps. This assay demonstrated that gaps are intrinsically elevated in BRCA-deficient cells independent of exogenous DNA damage. These gaps arose during DNA replication and were generated through PRIMPOL-dependent repriming at abasic sites and nuclease-mediated processing. Across diverse cell line models, PARP inhibitor (PARPi) sensitivity was associated with gap burden irrespective of BRCA status, extending the relevance of this vulnerability beyond canonical BRCA-mutant contexts. Integration with artificial intelligence–driven image analysis enabled automated, unbiased quantification of gap levels in xenograft tumor specimens. In BRCA-deficient xenografts, elevated gap levels were associated with PARPi sensitivity, supporting their translational relevance in relation to therapeutic response. Together, these findings establish ssDNA gaps as a real-time functional readout associated with chemotherapy response and introduce an assay with potential for future clinical translation. Significance: Single-stranded DNA gaps are an intrinsic feature of therapy-sensitive cancer cells, representing a functional biomarker that captures replication-associated vulnerabilities.
- 8 September 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 86 (22) , 5822-5836
Open AccessDetection of Single-Stranded DNA Gaps Reveals a Functional Biomarker of Therapeutic Response
Single-stranded DNA (ssDNA) gaps represent an underappreciated vulnerability that directly shapes therapeutic response in BRCA-deficient models. Current clinical biomarkers remain anchored to the double-strand break–centric model of homologous recombination deficiency, and there are currently no tools available to detect replication-associated gaps in the clinical setting. In this study, we developed a scalable, clinically adaptable assay that enables real-time, drug-free detection of gaps. This assay demonstrated that gaps are intrinsically elevated in BRCA-deficient cells independent of exogenous DNA damage. These gaps arose during DNA replication and were generated through PRIMPOL-dependent repriming at abasic sites and nuclease-mediated processing. Across diverse cell line models, PARP inhibitor (PARPi) sensitivity was associated with gap burden irrespective of BRCA status, extending the relevance of this vulnerability beyond canonical BRCA-mutant contexts. Integration with artificial intelligence–driven image analysis enabled automated, unbiased quantification of gap levels in xenograft tumor specimens. In BRCA-deficient xenografts, elevated gap levels were associated with PARPi sensitivity, supporting their translational relevance in relation to therapeutic response. Together, these findings establish ssDNA gaps as a real-time functional readout associated with chemotherapy response and introduce an assay with potential for future clinical translation. Significance: Single-stranded DNA gaps are an intrinsic feature of therapy-sensitive cancer cells, representing a functional biomarker that captures replication-associated vulnerabilities.
- Open Access
- 21 October 2021
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 17 (10) , e1009863
Restarted replication forks are error-prone and cause CAG repeat expansions and contractions
Disease-associated trinucleotide repeats form secondary DNA structures that interfere with replication and repair. Replication has been implicated as a mechanism that can cause repeat expansions and contractions. However, because structure-forming repeats are also replication barriers, it has been unclear whether the instability occurs due to slippage during normal replication progression through the repeat, slippage or misalignment at a replication stall caused by the repeat, or during subsequent replication of the repeat by a restarted fork that has altered properties. In this study, we have specifically addressed the fidelity of a restarted fork as it replicates through a CAG/CTG repeat tract and its effect on repeat instability. To do this, we used a well-characterized site-specific replication fork barrier (RFB) system in fission yeast that creates an inducible and highly efficient stall that is known to restart by recombination-dependent replication (RDR), in combination with long CAG repeat tracts inserted at various distances and orientations with respect to the RFB. We find that replication by the restarted fork exhibits low fidelity through repeat sequences placed 2–7 kb from the RFB, exhibiting elevated levels of Rad52- and Rad8ScRad5/HsHLTF-dependent instability. CAG expansions and contractions are not elevated to the same degree when the tract is just in front or behind the barrier, suggesting that the long-traveling Polδ-Polδ restarted fork, rather than fork reversal or initial D-loop synthesis through the repeat during stalling and restart, is the greatest source of repeat instability. The switch in replication direction that occurs due to replication from a converging fork while the stalled fork is held at the barrier is also a significant contributor to the repeat instability profile. Our results shed light on a long-standing question of how fork stalling and RDR contribute to expansions and contractions of structure-forming trinucleotide repeats, and reveal that tolerance to replication stress by fork restart comes at the cost of increased instability of repetitive sequences.
- 21 October 2021
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 17 (10) , e1009863
Open AccessRestarted replication forks are error-prone and cause CAG repeat expansions and contractions
Disease-associated trinucleotide repeats form secondary DNA structures that interfere with replication and repair. Replication has been implicated as a mechanism that can cause repeat expansions and contractions. However, because structure-forming repeats are also replication barriers, it has been unclear whether the instability occurs due to slippage during normal replication progression through the repeat, slippage or misalignment at a replication stall caused by the repeat, or during subsequent replication of the repeat by a restarted fork that has altered properties. In this study, we have specifically addressed the fidelity of a restarted fork as it replicates through a CAG/CTG repeat tract and its effect on repeat instability. To do this, we used a well-characterized site-specific replication fork barrier (RFB) system in fission yeast that creates an inducible and highly efficient stall that is known to restart by recombination-dependent replication (RDR), in combination with long CAG repeat tracts inserted at various distances and orientations with respect to the RFB. We find that replication by the restarted fork exhibits low fidelity through repeat sequences placed 2–7 kb from the RFB, exhibiting elevated levels of Rad52- and Rad8ScRad5/HsHLTF-dependent instability. CAG expansions and contractions are not elevated to the same degree when the tract is just in front or behind the barrier, suggesting that the long-traveling Polδ-Polδ restarted fork, rather than fork reversal or initial D-loop synthesis through the repeat during stalling and restart, is the greatest source of repeat instability. The switch in replication direction that occurs due to replication from a converging fork while the stalled fork is held at the barrier is also a significant contributor to the repeat instability profile. Our results shed light on a long-standing question of how fork stalling and RDR contribute to expansions and contractions of structure-forming trinucleotide repeats, and reveal that tolerance to replication stress by fork restart comes at the cost of increased instability of repetitive sequences.